ISB
© Credits

Accelerating impact of innovations for health

“The scale-up of effective, quality health innovations requires a better understanding of barriers to implementation and uptake to reach the most vulnerable populations. It also requires support in linking the health demand and supply of innovations in countries. WHO will apply a new collaborative approach to scaling innovations in health (‘the WHO Innovation Scaling Framework’), aimed at linking the health demand in countries with the supply of mature, assessed innovations.  

WHO will also support research to address barriers to health impact, strengthen primary health care systems, and innovate delivery of interventions to achieve universal health coverage. WHO will also examine the ethical, social, and public health aspects of emerging technologies.”

 

WHO compendium of innovative health technologies for low-resource settings

The objective of the WHO Compendium is to compile and showcase emerging innovative health technologies for low-resource settings. WHO performs evidence-based assessments focused on the life cycle of health technology innovations for low-resource settings. The evaluation includes:

  • General technology details
  • WHO specification comparison
  • Regulatory assessment
  • Technology evidence assessment
  • Health technology and engineering management assessment
  • Intellectual property and local production assessment

The WHO Compendium presents manufacturer-reported information and WHO assessment results. It focuses on health technologies which have the potential to improve health outcomes and quality of life, or to offer a solution to an unmet medical/health technology need.  The WHO compendium sheds light on advantages and challenges associated with implementing health technologies in low-resource settings and can be used by NGOs, governments, and other stakeholders to support procurement decisions.

The WHO Compendium acknowledges success stories and raises awareness of the pressing need for appropriate and affordable design solutions. It also promotes innovation in the field. This effort aims to promote interaction among ministries of health, procurement officers, donors, technology developers, manufacturers, clinicians, academics and the general public. Ultimately, it ensure greater investment in health technology towards universal access to essential health technologies.

2023 Call for innovative health technologies for low-resource settings.

The 2023 Call was closed on October 31, 2023, and it focused on technologies to address noncommunicable diseases. Noncommunicable diseases (NCDs) kill 41 million people each year, equivalent to 74% of all deaths globally. Each year, 17 million people die from a NCD before age 70; 86% of these premature deaths occur in low- and middle-income countries.

The 2023 Call received submissions for commercially available technologies and prototypes. In addition, WHO received updates for technologies previously featured in the Compendium. Despite the focus on NCDs, the call considered submissions of technologies related to other diseases and health conditions.

Thank you for all your submissions!

If you are planning to submit your innovation to future calls, please consider that the assessment is extensive. WHO requires innovators to complete a questionnaire and provide all available evidence and relevant documentation to all claims sustained in the questionnaire. The WHO assessment includes the following sections: General technology details, WHO technical specification comparison, Regulatory assessment, Health technology evidence assessment, Health technology management assessment, and Local production and intellectual property assessment.

 

WHO compendium of innovative health technologies for low-resource settings 2022

The objective of the 2022 Compendium is to compile and highlight emerging innovative health technologies for low-resource settings. It presents a...

WHO compendium of innovative health technologies for low-resource settings 2021. COVID-19 and other health priorities

Health technologies, specially medical devices are essential for a functioning health system. The  response  to  the  global ...

WHO compendium of innovative health technologies for low-resource settings, 2016- 2017

WHO compendium of innovative health technologies for low – resource settings 2016-2017 provides information about novel advancements that offer a...

WHO compendium of innovative health technologies for low resource settings, 2011-2014

This is a continuation of the compendium series of innovative medical devices, assistive devices and eHealth solutions, inclusive of 2011-2014. The objective...

Compendium of innovative health technologies for low-resource settings

The objective of the compendium series of innovative medical devices, assistive devices and eHealth solutions is to provide a neutral platform for technologies...

Medical devices and eHealth solutions: compendium of innovative health technologies for low-resource settings 2011-2012

The compendium series of innovative medical devices and eHealth solutions has been created as a neutral platform for technologies which are likely to...

Compendium of new and emerging health technologies

The compendium of new and emerging technologies that address global health concerns has been created as a neutral platform for technologies which are...

Related events

Health innovation for impact

Solar-Powered Oxygen:  Saving Lives with the WHO Innovation Scaling Framework 

This child is receiving oxygen through a solar-powered concentrator – an innovative solution that can save lives in places with frequent power shortages, such as this hospital in Somalia.

Pneumonia accounts for 800 000 deaths per year of which 20-40 % could be saved with oxygen. The COVID-19 pandemic has further accelerated global demand for medical oxygen.

In early 2021, solar-powered oxygen concentrators were installed in a regional children’s hospital in Galmudug state, Somalia. Since its installations many more lives have been saved compared to the previous situation.

The innovation was installed thanks to a new WHO Innovation Scaling framework – a WHO facilitated multi-partner approach to innovation scaling. Under the leadership of the WHO Country, Regional and government partners, and facilitated by the WHO Innovation team, along with important contributions from WHO technical departments, innovators and funders, this pilot illustrates how innovation can go hand in hand with existing programmes and help address barriers to existing programmes, such as energy supply, affordability, access, and training.  

WHO’s Innovation Scaling Framework illustrates the multi-partner collaborative approach WHO is taking to scaling innovation by linking three dimensions of innovation scaling: 1) the health demands and priorities of countries, 2) the supply of ready to scale innovations, and 3) innovation assessment throughout from incubating (through partners) to implementing and sustaining innovations.

 

Target product profiles

Preferred Product Characteristics for Personal Protective Equipment for the Health Worker on the Frontline Responding to Viral Hemorrhagic Fevers*in Tropical Climates

ObjectivesTo provide a review and summary of current evidence on protective effects of PPE and applicable standards, and to identify the knowledge gaps...

Consensus Meeting Report: Development of a Target Product Profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease

In May 2015, an Expert Consultation was convened by the World Health Organization (WHO) Geneva on behalf of the New Diagnostics Working Group, Stop TB...

High priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting

Diagnostic manufacturers are increasingly expressing the need to be informed about the type of TB diagnostics they should invest in, as well as the potential...

What is a target product profile?

A target product profile (TPP) outlines the desired ‘profile’ or characteristics of a medical product. TPPs state intended use, target populations and other desired attributes of products, including safety and efficacy-related characteristics. Such profiles can guide product research and development (R&D):

  • In industry, in-house target product profiles (TPPs) are used as planning tools that guide development towards desired characteristics.
  • In the regulatory context, TPPs are considered as tools to frame development in relation to submission of product dossiers.
  • In the context of public health, TPPs set R&D targets for funders and developers.

WHO target product profiles

WHO TPPs support the development of missing health products, keeping focus on public health priorities. WHO TPPs recognize that access, equity and affordability are integral parts of the innovation process and need to be considered at all stages, not just after a product is developed.

Innovation for COVID-19

WHO has been uniting with many partners to accelerate the development, production and equitable distribution of vaccines, diagnostics and therapeutics for COVID-19. Our shared commitment is to ensure all people have access to all the tools to defeat COVID-19. Therefore WHO has been enabling collaboration in innovation against COVID-19. Some key projects or resources are listed here.

 

Other publications on innovation